7,392 Shares in Colgate-Palmolive (NYSE:CL) Acquired by Promus Capital LLC

Promus Capital LLC acquired a new position in shares of Colgate-Palmolive (NYSE:CL) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 7,392 shares of the company’s stock, valued at approximately $672,000. Colgate-Palmolive comprises about 0.6% of Promus Capital LLC’s portfolio, making the stock its 25th biggest holding.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Chicago Partners Investment Group LLC lifted its stake in Colgate-Palmolive by 16.2% in the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after buying an additional 943 shares in the last quarter. Peak Financial Advisors LLC bought a new position in Colgate-Palmolive in the fourth quarter valued at approximately $1,315,000. Gordian Advisors LLC bought a new position in Colgate-Palmolive in the third quarter valued at approximately $602,000. Carrera Capital Advisors lifted its stake in Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after buying an additional 7,353 shares in the last quarter. Finally, Fiduciary Alliance LLC bought a new position in Colgate-Palmolive in the fourth quarter valued at approximately $4,066,000. Institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have weighed in on CL. Barclays cut their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Morgan Stanley cut their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. JPMorgan Chase & Co. cut their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. UBS Group cut their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. Finally, Piper Sandler cut their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $101.61.

Colgate-Palmolive Price Performance

NYSE:CL opened at $91.87 on Thursday. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The company has a market cap of $74.56 billion, a P/E ratio of 26.10, a P/E/G ratio of 4.20 and a beta of 0.44. The firm’s fifty day moving average price is $88.72 and its two-hundred day moving average price is $95.27. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the company earned $0.87 EPS. Equities analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were issued a $0.50 dividend. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.18%. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.